Intralesional Cryosurgery Alone Versus Combined With 5-FU and Triamcinolone for Keloids
Starting soon · Not applicable · Has a placebo group
Conditions studied: Keloid
In brief
evaluate the efficacy and safety of intralesional cryosurgery alone compared with intralesional cryosurgery combined with intralesional 5-fluorouracil and triamcinolone acetonide in the treatment of keloids.
Key facts
- Study ID
- NCT07526168
- Run by
- Assiut University
- People needed
- 32
- Starts
- 2026-07-01
- Expected to finish
- 2027-08-01
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (≥18 years) with clinically diagnosed keloids .
- Keloids of size 1-10 cm in greatest dimension .
- Keloids of at least one year duration
You may not qualify if…
- Females who are pregnant, planning pregnancy, or lactating .
- Hypertrophic scars .
- Chronic kidney or liver disease (relevant for 5-FU safety) .
- Patients with active inflammation, infection, or ulcer at or around the keloid or Lesions suspicious for malignancy .
- Patients who received any treatment for the same keloid in the past 12 months .
- Immunosuppressed patients or those with chronic inflammatory diseases .
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.